TY - JOUR
T1 - Detection of Bacterial Colonization in Lung Transplant Recipients Using an Electronic Nose
AU - Wijbenga, N
AU - de Jong, NLA
AU - Hoek, RAS
AU - Mathot, BJ
AU - Seghers, L
AU - Aerts, JGJV
AU - Bos, D
AU - Manintveld, OC
AU - Hellemons, ME
N1 - Publisher Copyright:
© 2023 Wolters Kluwer Health. All rights reserved.
PY - 2023/9/20
Y1 - 2023/9/20
N2 - Bacterial colonization (BC) of the lower airways is common in lung transplant recipients (LTRs) and increases the risk of chronic lung allograft dysfunction. Diagnosis often requires bronchoscopy. Exhaled breath analysis using electronic nose (eNose) technology may noninvasively detect BC in LTRs. Therefore, we aimed to assess the diagnostic accuracy of an eNose to detect BC in LTRs. Methods. We performed a cross-sectional analysis within a prospective, single-center cohort study assessing the diagnostic accuracy of detecting BC using eNose technology in LTRs. In the outpatient clinic, consecutive LTR eNose measurements were collected. We assessed and classified the eNose measurements for the presence of BC. Using supervised machine learning, the diagnostic accuracy of eNose for BC was assessed in a random training and validation set. Model performance was evaluated using receiver operating characteristic analysis. Results. In total, 161 LTRs were included with 80 exclusions because of various reasons. Of the remaining 81 patients, 16 (20%) were classified as BC and 65 (80%) as non-BC. eNose-based classification of patients with and without BC provided an area under the curve of 0.82 in the training set and 0.97 in the validation set. Conclusions. Exhaled breath analysis using eNose technology has the potential to noninvasively detect BC.
AB - Bacterial colonization (BC) of the lower airways is common in lung transplant recipients (LTRs) and increases the risk of chronic lung allograft dysfunction. Diagnosis often requires bronchoscopy. Exhaled breath analysis using electronic nose (eNose) technology may noninvasively detect BC in LTRs. Therefore, we aimed to assess the diagnostic accuracy of an eNose to detect BC in LTRs. Methods. We performed a cross-sectional analysis within a prospective, single-center cohort study assessing the diagnostic accuracy of detecting BC using eNose technology in LTRs. In the outpatient clinic, consecutive LTR eNose measurements were collected. We assessed and classified the eNose measurements for the presence of BC. Using supervised machine learning, the diagnostic accuracy of eNose for BC was assessed in a random training and validation set. Model performance was evaluated using receiver operating characteristic analysis. Results. In total, 161 LTRs were included with 80 exclusions because of various reasons. Of the remaining 81 patients, 16 (20%) were classified as BC and 65 (80%) as non-BC. eNose-based classification of patients with and without BC provided an area under the curve of 0.82 in the training set and 0.97 in the validation set. Conclusions. Exhaled breath analysis using eNose technology has the potential to noninvasively detect BC.
UR - http://www.scopus.com/inward/record.url?scp=85173252929&partnerID=8YFLogxK
U2 - 10.1097/TXD.0000000000001533
DO - 10.1097/TXD.0000000000001533
M3 - Article
C2 - 37745948
SN - 2373-8731
VL - 9
SP - E1533
JO - Transplantation Direct
JF - Transplantation Direct
IS - 10
M1 - e1533
ER -